Europe

Obtain the latest insights on mesothelioma clinical trials in Europe. Should you be doing chemotherapy or holistic instead? Learn More

Asbestos | Europe | International | Occupations | Statistics | Updates

Beyond Mesothelioma: Asbestos Linked to Digestive Cancers
ByAlex Strauss August 29, 2015March 16, 2017

Scientists have long known that mesothelioma, an aggressive cancer that affects the membrane around organs, is not the only cancer…

Read More Beyond Mesothelioma: Asbestos Linked to Digestive Cancers
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Prognosis | Research | Treatments | Updates

Improving Mesothelioma Response to Chemotherapy
ByAlex Strauss August 26, 2015March 16, 2017

Most mesothelioma patients will undergo chemotherapy at some point, whether in preparation for surgery or as a treatment by itself.…

Read More Improving Mesothelioma Response to Chemotherapy
Biological Therapy | Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Making Mesothelioma Cells More Susceptible to Chemotherapy
ByAlex Strauss August 22, 2015March 25, 2019

A potential new mesothelioma drug may have moved a step closer to gaining mainstream acceptance for use in sick patients.…

Read More Making Mesothelioma Cells More Susceptible to Chemotherapy
Asbestos | Biomarkers | Biopsy | Chemotherapy | Diagnosis | Europe | International | Scans | Statistics | Treatments | Updates

Irish Physicians Frustrated by Inadequate Training for Mesothelioma Diagnosis
ByAlex Strauss August 18, 2015March 16, 2017

Do general pulmonologists have the training they need to diagnose an illness as rare and challenging as mesothelioma? There is…

Read More Irish Physicians Frustrated by Inadequate Training for Mesothelioma Diagnosis
Asbestos | Europe | International | Occupations | Prognosis | Statistics | Updates

Mesothelioma-Causing Power of Asbestos Lingers Long After Contaminating Industry Leaves
ByAlex Strauss August 14, 2015March 16, 2017

There is more evidence that exposure to asbestos can dramatically increase the lifetime odds of developing malignant mesothelioma, even after…

Read More Mesothelioma-Causing Power of Asbestos Lingers Long After Contaminating Industry Leaves
Europe | Immune Systems | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments | Updates

Kidney Cancer Drug Slows Mesothelioma Growth in Mice
ByAlex Strauss August 8, 2015March 24, 2019

A drug that has been shown to slow the growth of renal cell carcinoma may have moved a step closer…

Read More Kidney Cancer Drug Slows Mesothelioma Growth in Mice
Biomarkers | Biopsy | Chemotherapy | Diagnosis | Europe | International | Mesothelioma Breaking News | Multi-Modality Therapy | Radiation Therapy | Surgery | Treatments | Updates

European Group Issues Updated Treatment Guidelines for Mesothelioma
ByAlex Strauss August 3, 2015March 23, 2019

A group of medical researchers has just released an updated set of clinical practice guidelines for treating patients with malignant…

Read More European Group Issues Updated Treatment Guidelines for Mesothelioma
Asbestos | Europe | International | New Studies | Research | Statistics | Updates

Scientific Evidence That Asbestos Bans Prevent Mesothelioma
ByAlex Strauss July 22, 2015March 26, 2019

There is some hopeful news on the mesothelioma front this week. A new study conducted in Sweden suggests asbestos bans…

Read More Scientific Evidence That Asbestos Bans Prevent Mesothelioma
Australia | Europe | International | Mesothelioma | Prognosis | Statistics | Surgery | Treatments | Updates

Predicting Long-Term Mesothelioma Survival After Surgery
ByAlex Strauss July 18, 2015April 1, 2019

Most mesothelioma patients and their families have heard the poor survival statistics associated with this aggressive cancer. But two new…

Read More Predicting Long-Term Mesothelioma Survival After Surgery
Chemotherapy | Europe | International | New Drugs | Treatments | Updates

Lower-Cost Mesothelioma Drug May Be as Effective as Gold Standard
ByAlex Strauss July 13, 2015March 25, 2019

A new study suggests that the lower cost chemotherapy drug Gemzar (gemcitabine) combined with a platinum based agent (cisplatin or…

Read More Lower-Cost Mesothelioma Drug May Be as Effective as Gold Standard

1 (888) 378-1331

Europe

Beyond Mesothelioma: Asbestos Linked to Digestive Cancers

Improving Mesothelioma Response to Chemotherapy

Making Mesothelioma Cells More Susceptible to Chemotherapy

Irish Physicians Frustrated by Inadequate Training for Mesothelioma Diagnosis

Mesothelioma-Causing Power of Asbestos Lingers Long After Contaminating Industry Leaves

Kidney Cancer Drug Slows Mesothelioma Growth in Mice

European Group Issues Updated Treatment Guidelines for Mesothelioma

Scientific Evidence That Asbestos Bans Prevent Mesothelioma

Predicting Long-Term Mesothelioma Survival After Surgery

Lower-Cost Mesothelioma Drug May Be as Effective as Gold Standard

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES